Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% |
|
-.--% | -.--% |
Verkoop per activiteit
USD in miljoen | 2002 | Gewicht | 2003 | Gewicht | Delta |
---|---|---|---|---|---|
Joint Development Agreement Revenue
nan
%
| 3 | 100,0 % | 0 | nan % | -100,00% |
Verkoop per regio
USD in miljoen | 2002 | Gewicht | 2003 | Gewicht | Delta |
---|---|---|---|---|---|
United States
nan
%
| 3 | 100,0 % | 0 | nan % | -100,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Morrice
DFI | Director of Finance/CFO | - | - |
President | 68 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
President | 68 | - | |
Ian Morrice
DFI | Director of Finance/CFO | - | - |
Bedrijfsgegevens
Spencer Pharmaceutical, Inc.
8 Faneuil Hall Marketplace 3rd floor
02109, Boston
+
![Adres Spencer Pharmaceutical Inc.(SPPH)](https://cdn.zonebourse.com/static/address/120792711.png)
Sector
- Beurs
- Aandelen
- Koers SPPH
- Onderneming Spencer Pharmaceutical Inc.